Therefore, in bladder cancer, miR-20a may activate the MEK signaling pathway by inhibiting NR4A3, thereby promoting EMT and promoting the proliferation and metastasis of bladder cancer. The gene discussed is MAP2K7; the disease is urinary bladder carcinoma.